 CHERRY HILL, N.J., July 13, 2021 GLOBE NEWSWIRE -- Vyant Bio, Inc. Vyant Bio, the Company Nasdaq: VYNT, an emerging leader in novel drug discovery technologies, announced today that its wholly-owned subsidiary, StemoniX, Inc. StemoniX, was issued US Patent No. 11054408, titled High Throughput Optical Assay of Human Mixed Cell Population Spheroids by the United States Patent and Trademark Office USPTO. 